GOSS
Price
$1.25
Change
-$0.05 (-3.85%)
Updated
Jun 27 closing price
Capitalization
281.85M
44 days until earnings call
GSGTF
Price
$0.24
Change
-$0.08 (-25.00%)
Updated
Dec 31 closing price
Capitalization
31.39M
Interact to see
Advertisement

GOSS vs GSGTF

Header iconGOSS vs GSGTF Comparison
Open Charts GOSS vs GSGTFBanner chart's image
Gossamer Bio
Price$1.25
Change-$0.05 (-3.85%)
Volume$26.07M
Capitalization281.85M
Gensight Biologics SA
Price$0.24
Change-$0.08 (-25.00%)
Volume$4.01K
Capitalization31.39M
GOSS vs GSGTF Comparison Chart in %
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. GSGTF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and GSGTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (GOSS: $1.25 vs. GSGTF: $0.24)
Brand notoriety: GOSS and GSGTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 1262% vs. GSGTF: 100%
Market capitalization -- GOSS: $281.85M vs. GSGTF: $31.39M
GOSS [@Biotechnology] is valued at $281.85M. GSGTF’s [@Biotechnology] market capitalization is $31.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileGSGTF’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • GSGTF’s FA Score: 0 green, 5 red.
According to our system of comparison, GOSS is a better buy in the long-term than GSGTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 2 TA indicator(s) are bullish.

  • GOSS’s TA Score: 2 bullish, 6 bearish.

Price Growth

GOSS (@Biotechnology) experienced а -13.19% price change this week, while GSGTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($282M) has a higher market cap than GSGTF($31.4M). GOSS YTD gains are higher at: 38.183 vs. GSGTF (0.000).
GOSSGSGTFGOSS / GSGTF
Capitalization282M31.4M898%
EBITDA-35.7MN/A-
Gain YTD38.1830.000-
P/E RatioN/AN/A-
Revenue125MN/A-
Total Cash258MN/A-
Total Debt203MN/A-
FUNDAMENTALS RATINGS
GOSS vs GSGTF: Fundamental Ratings
GOSS
GSGTF
OUTLOOK RATING
1..100
5350
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4380
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOSS's Valuation (60) in the Pharmaceuticals Major industry is in the same range as GSGTF (85) in the null industry. This means that GOSS’s stock grew similarly to GSGTF’s over the last 12 months.

GOSS's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as GSGTF (100) in the null industry. This means that GOSS’s stock grew similarly to GSGTF’s over the last 12 months.

GSGTF's SMR Rating (99) in the null industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that GSGTF’s stock grew similarly to GOSS’s over the last 12 months.

GOSS's Price Growth Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for GSGTF (80) in the null industry. This means that GOSS’s stock grew somewhat faster than GSGTF’s over the last 12 months.

GOSS's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as GSGTF (100) in the null industry. This means that GOSS’s stock grew similarly to GSGTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSS
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NVDY16.710.19
+1.15%
YieldMax NVDA Option Income Strategy ETF
OAIM38.080.27
+0.71%
OneAscent International Equity ETF
PMARX12.470.04
+0.32%
Victory Pioneer Equ Premium Income A
GDSTX25.480.01
+0.04%
Goldman Sachs Small Cap Eq Insghts Inv
SIXH38.28N/A
N/A
ETC 6 Meridian Hdg Eq-Idx Opt Strat ETF

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-3.85%
MEIP - GOSS
46%
Loosely correlated
+4.09%
CGEM - GOSS
45%
Loosely correlated
+0.13%
APVO - GOSS
41%
Loosely correlated
-4.64%
VIR - GOSS
41%
Loosely correlated
-2.64%
CLLS - GOSS
37%
Loosely correlated
-2.54%
More

GSGTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSGTF
1D Price
Change %
GSGTF100%
N/A
HRTX - GSGTF
45%
Loosely correlated
-0.93%
RPTX - GSGTF
34%
Loosely correlated
-1.42%
GOSS - GSGTF
30%
Poorly correlated
-3.85%
BVAXF - GSGTF
29%
Poorly correlated
N/A
SPRC - GSGTF
29%
Poorly correlated
+0.72%
More